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Background: Studies report increases in rates of gestational diabetes mellitus (GDM) over recent decades.
Environmental chemicals may increase the risk of diabetes through impacts on glucose metabolism,
mitochondrial dysfunction, and endocrine-disrupting mechanisms including effects on pancreatic β-cell
function and adiponectin release.
Objectives: To determine the associations between pesticides, perﬂuoroalkyl substances (PFASs) and
polychlorinated biphenyls (PCBs) measured in early pregnancy and impaired glucose tolerance (IGT) and
GDM in a Canadian birth cohort.
Methods: Women enrolled in the Maternal-Infant Research on Environmental Chemicals (MIREC) Study
were included if they had a singleton delivery and did not have pre-existing diabetes. Exposure variables
included three organophosphorus (OP) pesticide metabolites detected in ﬁrst-trimester urine samples, as
well as three organochlorine (OC) pesticides, three PFASs, and four PCBs in ﬁrst-trimester blood samples.
Gestational IGT and GDM were assessed by chart review in accordance with published guidelines. Ad-
justed logistic regression models were used to calculate odds ratios (ORs) and 95% conﬁdence intervals
(CI) for the association between quartiles of environmental chemicals and both gestational IGT and GDM.
Results: Of the 2001 women recruited into the MIREC cohort, 1274 met the inclusion criteria and had
outcome and biomonitoring data available. Signiﬁcantly lower odds of GDM were observed in the third
and fourth quartiles of dimethylphosphate (DMP) and in the fourth quartile of dimethylthiophosphate
(DMTP) in adjusted analyses (DMP Q3: OR¼0.2, 95% CI¼0.1–0.7; DMP Q4: OR¼0.3, 95% CI¼0.1–0.8;
DMTP: OR¼0.3, 95% CI¼0.1–0.9). Signiﬁcantly elevated odds of gestational IGT was observed in the
second quartile of perﬂuorohexane sulfonate (PFHxS) (OR¼3.5, 95% CI¼1.4–8.9). No evidence of asso-
ciations with GDM or IGT during pregnancy was observed for PCBs or OC pesticides.
Conclusions: We did not ﬁnd consistent evidence for any positive associations between the chemicals we
examined and GDM or IGT during pregnancy. We observed statistical evidence of inverse relationships
between urine concentrations of DMP and DMTP with GDM. We cannot rule out the inﬂuence of residualInc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Survey; DDE, p,p′-dichlorodiphenyldichloroethylene; DEP, diethylphosphate; DMP, dimethylphosphate; DMTP, di-
litus; IGT, impaired glucose tolerance; LOD, limit of detection; MIREC, Maternal-Infant Research on Environmental
s; OR, odds ratio; PCB, polychlorinated biphenyl; PCB118, 2,3′,4,4′,5-pentachlorobiphenyl; PCB138, 2,2′,3,4,4′,5′-hex-
enyl; PCB180, 2,2′,3,4,4′,5,5′-heptachlorobiphenyl; PFAS, perﬂuoroalkyl substance; PFHxS, perﬂuorohexane sulfonate;
sulfonate
rch Unit, 7th Floor Women's Site, IWK Health Centre, 5980 University Ave., PO Box 9700, Halifax, NS, Canada B3H 6R8.
G.D. Shapiro et al. / Environmental Research 147 (2016) 71–8172confounding due to unmeasured protective factors, such as nutritional beneﬁts from fruit and vegetable
consumption, also associated with pesticide exposure, on the observed inverse associations between
maternal OP pesticide metabolites and GDM. These ﬁndings require further investigation.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes is a substantial and growing public health problem
(International Diabetes Federation, 2013), and increasing rates of
gestational diabetes mellitus (GDM) form part of this trend (Da-
venport et al., 2010; Feig et al., 2014; Galtier, 2010). Evidence
suggests that the etiology of diabetes is likely multifactorial (Public
Health Agency of Canada, 2011) and that environmental chemicals
may play a role along with more traditional risk factors such as
excess caloric consumption, lack of physical activity and increased
BMI (Bezek et al., 2008; Kuo et al., 2013; Thayer et al., 2012).
However, examination of the environmental chemical hypothesis
with regards to GDM has been more limited (Ettinger et al., 2009;
Robledo et al., 2013; Saldana et al., 2007; Saunders et al., 2014).
The potential health effects of perinatal chemical exposures
(Newbold, 2011) and GDM (Aerts and Van Assche, 2006; Osgood
et al., 2011) are a concern for subsequent maternal and offspring
metabolic health.
Organophosphates (OPs) are the most widely used class of
pesticides for agricultural and landscape pest control (Rezg et al.,
2010). The primary route of exposure is via ingestion of con-
taminated food (Lu et al., 2008). These pesticides are metabolized
relatively quickly and are not persistent in the environment
(Lambert et al., 2005). The dialkyl phosphate metabolites, rather
than the parent compounds, are used as non-speciﬁc biomarkers
of exposure in urine. Evidence from human and animal studies
supports a potential role for OPs in the development of obesity and
type 2 diabetes (Rahimi and Abdollahi, 2007; Rezg et al., 2010).
Epidemiologic studies have also shown associations between
organochlorine (OC) pesticides and diabetes (Azandjeme et al.,
2014; Cox et al., 2007; Gray et al., 2013; Hectors et al., 2011; Lee
et al., 2011a; Philibert et al., 2009; Rignell-Hydbom et al., 2009,
2007; Son et al., 2010; Turyk et al., 2009a, 2009b; Ukropec et al.,
2010). While OC pesticides are no longer registered for use in
Canada, they are persistent in the environment, and trace amounts
may still be found in food products. Finally, epidemiologic evi-
dence also suggests a potential role for other classes of chemicals
including perﬂuoroalkyl substances (PFASs) (Lin et al., 2009;
Steenland et al., 2010; Zhang et al., 2015) and polychlorinated bi-
phenyls (PCBs) (Carpenter, 2008; Everett et al., 2011) in the de-
velopment of diabetes.
The above-mentioned chemical classes are hypothesized to
increase risk of diabetes through modulation of glucose metabo-
lism (OP compounds and PFAS) (Hectors et al., 2011; Lv et al., 2013;
Rahimi and Abdollahi, 2007), mitochondrial dysfunction (OC pes-
ticides and PCBs) (Lee et al., 2014), and endocrine-disrupting
mechanisms (OC pesticides and PCBs) (Lee et al., 2014) including
effects on pancreatic β-cell function (PCBs) (Gray et al., 2013;
Hectors et al., 2011) and adiponectin release (OC compounds)
(Howell and Mangum, 2011). However, exploration of these che-
micals in relation to GDM has been limited (Saldana et al., 2007;
Saunders et al., 2014). In light of the current literature, we
speculated that exposure to the above-mentioned chemical classes
may be associated with GDM or impaired glucose tolerance (IGT)
during pregnancy. Using data from a Canadian birth cohort, the
present study sought to determine whether exposure to OP or OC
pesticides, PFAS or PCBs, measured early in pregnancy in maternalblood and urine, was associated with increased risk of GDM or IGT
during pregnancy.2. Materials and methods
2.1. Study sample
The Maternal-Infant Research on Environmental Chemicals
(MIREC) Study is a longitudinal birth cohort study conducted in
Canada. Further details concerning inclusion and exclusion criteria
and study objectives and procedures have been published else-
where (Arbuckle et al., 2013). The present analysis used the same
subset of the MIREC study sample as our previous work looking at
GDM and gestational IGT in relation to metals and phthalates
(Shapiro et al., 2015). Brieﬂy, participants were included if they
gave birth to a live singleton, had sufﬁcient data from the glucose
challenge test (GCT) and/or oral glucose tolerance test (OGTT) to
determine a diagnosis of GDM and gestational IGT, and had ex-
posure data available for at least one of the chemicals investigated
(PCBs, OC pesticides, OPs, and PFASs). All participants signed in-
formed consent forms and the study received ethical approval
from Health Canada and all the study centres.
2.2. Chemical Biomonitoring data
First trimester urine samples were analysed for six OP pesticide
metabolites (diethylphosphate (DEP), diethyldithiophosphate (DEDTP),
diethylthiophosphate (DETP), dimethylphosphate (DMP), di-
methylthiophosphate (DMTP), dimethyldithiophosphate (DMDTP)).
Eleven OC pesticides (p,p′-dichlorodiphenyldichloroethylene (DDE),
oxychlordane, trans-nonachlor, aldrin, alpha-chlordane, gamma-
chlordane, cis-onachlor, gamma-hexachlorocylcohexane (γ-HCH),
p,p′-dichlorodiphenyltrichloroethane (p,p′-DDT), hexachlorobenzene
(HCB), mirex)), three PFASs (perﬂuorooctanoic acid (PFOA), per-
ﬂuorooctane sulfonate (PFOS), perﬂuorohexane sulfonate (PFHxS)),
and 24 PCBs were measured in ﬁrst trimester plasma samples. We
focused our analyses on exposures for which there were detectable
levels in 475% of subjects. This included three OP pesticide meta-
bolites (DEP, DMP, DMTP), three OC pesticides (p,p′- DDE, oxychlor-
dane, trans-nonachlor), all three PFASs and four PCB congeners
(2,3′,4,4′,5-pentachlorobiphenyl (PCB118), 2,2′,3,4,4′,5′-hexachloro-
biphenyl (PCB138), 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153), 2,2′,3,
4,4′,5,5′-heptachlorobiphenyl (PCB180)).
All chemical analyses were carried out at the Toxicology Centre
of the Quebec Institute of Public Health (Institut national de santé
publique du Québec), accredited by the Standards Council of Ca-
nada under ISO 17025 and CAN-P-43. The accuracy and precision
of the analyses are evaluated on a regular basis through the la-
boratory's participation in external quality assessment programs
(Arbuckle et al., 2013). OC pesticides and PCBs were analyzed by
gas chromatography—mass spectrometry using the Agilent 6890N/
5973. Plasma samples were enriched with internal standards and
halogenated organic compounds were retrieved by liquid-liquid
extraction with a mixture of ammonium sulfate:ethanol:hexane
(1:1:3). Extracts were concentrated, automatically puriﬁed on
ﬂorisil column and then analyzed by gas chromatography coupled
Table 1
Study sample characteristics (N¼1274).
Variable n (%)
Age r29 308 (24.2)
30–34 447 (35.1)
Z35 515 (40.4)
Missing 4 (0.3)
Pre-pregnancy BMI (kg/m2) Underweight or Normal (o25)a 752 (59.0)
Overweight (25–29.9) 257 (20.2)
Obese (Z30) 191 (15.0)
Missing 74 (5.8)
Parity Nulliparous 563 (44.2)
Parous 709 (55.7)
Missing 2 (0.2)
Education High school diploma or less 106 (8.3)
Some college, or trade school 352 (27.6)
Undergraduate university degree 477 (37.4)
Graduate university degree 338 (26.5)
Missing 1 (0.1)
Household Income ($CAD) r50,000 209 (16.4)
50,001–100,000 505 (39.6)
Z100,000 506 (39.7)
Missing 54 (4.2)
Race White 1077 (84.5)
Non-White 197 (15.5)
Smoking Never or quit before pregnancy 1124 (88.2)
Quit when knew pregnant 93 (7.3)
Current smoker 56 (4.4)
Missing 1 (0.1)
a Underweight and Normal BMI were combined because of the small number
of underweight participants (34 (2.7%)).
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negative chemical ionization were performed in selective ion
mode. PFASs were analyzed using the Waters Acquity
UPLC-MS-MS. Analytes were extracted at alkaline pH with methyl
tertbutyl ether and ion pairing with tetrabutylammonium hydro-
gensulfate, evaporated to dryness and dissolved in the mobile
phase. They were then analyzed by UPLCMS-MS operated in the
MRM mode with an electrospray ion source in negative mode.
Concentrations below the limit of detection (LOD) were sub-
stituted as one half the LOD.
2.3. Impaired glucose tolerance in pregnancy and gestational dia-
betes mellitus
Gestational IGT and GDM were assessed by chart review based
on the results of a 50 g glucose challenge test (GCT) and 75 or
100 g oral glucose tolerance test (OGTT), in accordance with
guidelines from the Canadian Diabetes Association and the Society
of Obstetricians and Gynaecologists of Canada (Berger et al., 2002;
Canadian Diabetes Association Clinical Practice Guidelines Expert
Committee, 2008). The algorithm used to calculate gestational IGT
and GDM is described in our previous work with this cohort
(Shapiro et al., 2015). Brieﬂy, gestational IGT was diagnosed if one
of the OGTT cut-off values was met or exceeded, whereas GDM
required at least 2 values at or above the cut-off values.
2.4. Statistical analyses
Descriptive statistics for maternal demographic and clinical
characteristics were calculated according to study outcomes
(normal blood glucose, gestational IGT, GDM) using frequency
distributions and chi-square tests of signiﬁcance. Geometric
means and standard deviations were calculated for chemical
concentrations according to study outcomes. In determining the
geometric mean, concentrations of OP pesticide metabolites were
adjusted for urinary speciﬁc gravity (SG) according to the follow-
ing formula: Pc¼Pi [(SGm1)/(SGi1)], where Pc¼SG-adjusted
metabolite concentration (mg/ml), Pi¼observed metabolite con-
centration, SGi¼speciﬁc gravity of the urine sample, and
SGm¼median SG for the cohort (Just et al., 2010).
All contaminant concentrations were grouped into quartiles for
analyses, and logistic regression models were used to examine
associations between quartiles and study outcomes. In calculating
odds ratios for these outcomes, we examined subjects with GDM
vs. normal blood glucose, gestational IGT vs. normal glucose, and
subjects with either gestational IGT or GDM grouped together vs.
normal blood glucose. In addition to the individual contaminants,
we also examined the summed molar concentrations of dimethyl
OP metabolites (DMP and DMTP) (Arcury et al., 2006), the sum of
all PCBs, sum of non-dioxin-like PCBs (PCBs 138, 153 and 180), and
the PCB mixture Aroclor 1260 (calculated by multiplying the sum
of the wet weight concentration of PCBs 153 and 138 by 5.2
(Health Canada, 2010)).
We examined the following maternal variables as potential
confounders: age at delivery, pre-pregnancy BMI (o25, 25-29.9,
Z30 kg/m2), parity (nulliparous vs. parous), household income
(r$30,000, 30,001–50,000, 50,001–100,000, 4100,000), educa-
tion (high school diploma or less, some college or trade school,
undergraduate university degree, graduate university degree), race
(White, non-White), and smoking (never or quit before pregnancy,
quit when knew pregnant, current smoker). Variables were se-
lected a priori for inclusion in multivariable models on the basis of
association with gestational IGT and GDM in univariate analyses
(po0.1) or on the basis of evidence of an association from the
literature. Speciﬁc gravity was included as a covariate in all ad-
justed models for OP pesticide metabolites to account forheterogeneity in urinary dilution (Arbuckle et al., 2014). Total li-
pids were included as a covariate in all adjusted models for PCBs
and OC pesticides (Schisterman et al., 2005). In light of collinearity
between income and education, and as model results were not
substantially different with adjustment for both income and
education vs. adjustment for education only, we did not adjust for
income in the ﬁnal models.
For models with statistically signiﬁcant associations, we used
restricted cubic spline analysis to further examine the dose-re-
sponse relationship (Desquilbet and Mariotti, 2010). This techni-
que is applicable when there is no a priori hypothesis regarding
the shape of the dose-response association, and it overcomes in-
herent limitations of our categorical analyses. Knots were set at
the 5th, 50th, and 95th percentiles and the referent value was set
to the 5th percentile. Regression analyses were carried out using
IBM-SPSS for Windows version 20 and spline analyses were car-
ried out using SAS 9.4.3. Results
Of the 2001 women recruited, 18 withdrew and asked that all
their data and biospecimens be destroyed (0.9%). Of the remaining
1983 subjects, 97 in total were excluded (4.9%) because of a mul-
tiple pregnancy (n¼48), stillbirth (n¼21), pre-existing diabetes
(n¼24), or having no biological samples available for the mea-
surement of any of the contaminants of interest (n¼4), leaving
1886 subjects. Of these, information from a GCT or OGTT was
available to calculate the study outcomes for 1274 women (67.6%).
Excluded participants were slightly less likely to be obese (10.3%
vs. 15.0% of included participants, p¼ .05) and slightly more likely
to report being White (88.1% vs. 84.5%, p¼ .04) and to be current
smokers (7.5% vs. 4.4%, p¼ .04).
Table 1 shows the characteristics of the study sample. Partici-
pants were between the ages of 18 and 49 (mean (SD)¼33.0 (4.9)
years), with 40% aged 35 or older. Twenty percent of participants
were overweight before becoming pregnant and 15% were obese.
Table 2
Geometric mean of organophosphorus pesticide metabolites, organochlorine pesticides, perﬂuoroalkyl substances, and polychlorinated biphenyls by GDM and gestational
IGT outcomes.
Chemical (μg/L) LOD % 4LODa Total Nb Geometric Mean (SD)
Normal glucose N¼1167 Gestational IGT cases N¼48 GDM cases N¼59
Organophosphorus pesticide metabolitesc
Diethylphosphate (DEP) 1.00 77.8 1247 2.50 (2.33) 2.55 (2.67) 2.28 (2.42)
Dimethylphosphate (DMP) 1.00 79.8 1246 3.34 (2.68) 2.18 (2.94) 2.22 (2.53)
Dimethylthiophosphate (DMTP) 0.60 81.0 1245 3.64 (3.94) 2.25 (5.23) 2.18 (3.52)
Organochlorine pesticides
p,p′-Dichlorodiphenyldichloroethylene (DDE) 0.09 98.2 1250 0.36 (2.36) 0.47 (2.90) 0.32 (1.95)
Oxychlordane 0.005 90.8 1249 0.012 (1.919) 0.012 (1.926) 0.012 (2.030)
Trans-Nonachlor 0.01 84.0 1249 0.017 (1.968) 0.019 (2.161) 0.017 (2.121)
Perﬂuoroalkyl substances
Perﬂuorooctanoic acid (PFOA) 0.10 99.8 1259 1.68 (1.80) 1.70 (1.73) 1.64 (1.64)
Perﬂuorooctane sulfonate (PFOS) 0.30 99.8 1259 4.58 (1.81) 4.29 (1.60) 4.74 (1.67)
Perﬂuorohexane sulfonate (PFHxS) 0.20, 0.30 96.1 1259 1.02 (2.31) 1.00 (1.79) 1.05 (2.03)
Polychlorinated biphenyls
2,3′,4,4′,5-Pentachlorobiphenyl (PCB118) 0.01 74.7 1250 0.014 (2.057) 0.015 (2.088) 0.014 (2.091)
2,2′,3,4,4′,5′-Hexachlorobiphenyl (PCB138) 0.01 92.9 1250 0.026 (2.118) 0.028 (2.135) 0.025 (2.223)
2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB153) 0.01 97.9 1250 0.047 (2.129) 0.048 (2.218) 0.044 (2.212)
2,2′,3,4,4′,5,5′-Heptachlorobiphenyl (PCB180) 0.01 92.2 1250 0.030 (2.371) 0.030 (2.271) 0.029 (2.470)
Aroclor 1260 0.10 98.1 1250 0.381 (2.112) 0.396 (2.152) 0.365 (2.157)
a The following chemicals had less than 75% of the samples above the LOD and were excluded from further analyses: Organophosphorus pesticide metabolites: Die-
thylthiophosphate (DETP), Diethyldithiophosphate (DEDTP), Dimethyldithiophosphate (DMDTP); Organochlorine Pesticides: Aldrin, alpha-Chlordane, gamma-Chlordane,
cis-Nonachlor, gamma-Hexachlorocylcohexane (γ-HCH), p,p′-Dichlorodiphenyltrichloroethane (p,p′-DDT), Hexachlorobenzene (HCB), Mirex; PCBs: 28, 52, 66, 74, 99, 101,
105, 128, 146, 156, 163, 167, 170, 178, 183, 187, 194, 201, 203, 206.
b Number of subjects with data available for each exposure.
c Geometric mean concentrations for organophosphorus pesticide metabolites are adjusted for urinary speciﬁc gravity.
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degree, and more than a quarter had a graduate degree. Forty
percent of participants had an annual household income of at least
$100,000 Canadian, while only 16% had household income below
$50,000. Fifteen percent of participants reported non-White race,
and less than 5% of study subjects smoked during pregnancy.
Forty-eight participants (3.8%) were identiﬁed as GDM cases and
59 (4.6%) were identiﬁed as having gestational IGT. The distribu-
tion of maternal characteristics by diabetes status has been de-
scribed in our previous work (Shapiro et al., 2015). As expected,
GDM and gestational IGT cases were more likely to be overweight
or obese compared to subjects with normal blood glucose.
Table 2 shows the percentage of samples above the LOD and
the geometric mean for each chemical analyzed, stratiﬁed by the
three outcome categories (normal blood glucose, gestational IGT,
GDM). Pearson correlations (data not shown) between OP pesti-
cide metabolites ranged from .26 (DEP and DMTP) to .66 (DMP and
DMTP). Correlations among OC pesticides ranged from .39 (DDE
and oxychlordane) to .82 (oxychlordane and trans-nonachlor).
Among PFASs, correlations ranged from .45 (PFOA and PFHxS) to
.56 (PFOA and PFOS), while correlations among PCB congeners
ranged from .65 (PCBs 118 and 180) to .96 (PCBs 138 and 153) (all
p-values for correlations between different chemicals in each class
were o0.01). Across chemical classes, the highest correlations
observed were those between OC pesticides and PCBs, which
ranged from 0.45 (DDE and PCB 180) to 0.59 (Transnonachlor and
PCB 138). Correlations between PFAS and both PCBs and OC pes-
ticides were below 0.3, and those between all other chemical
classes were below 0.1.
Table 3 shows the crude and adjusted odds ratios of each of the
study outcomes (GDM vs. normal glucose, gestational IGT vs.
normal glucose, gestational IGT or GDM vs. normal glucose) by
quartile of contaminant concentrations. In comparing odds of
GDM in the upper three quartiles vs. the lowest quartile for OP
pesticides, inverse associations were observed for DMP and DMTP.
Associations were statistically signiﬁcant for the third and fourth
quartiles of dimethylphosphate (DMP) and for the fourth quartileof dimethylthiophosphate (DMTP) (DMP Q3: OR¼0.2, 95%
CI¼0.1–0.7; DMP Q4: OR¼0.3, 95% CI¼0.1–0.8; DMTP: OR¼0.3,
95% CI¼0.1–0.9), with signiﬁcant dose-response relationships
observed across quartiles for both compounds. A similar pattern
was observed for the combined GDM/IGT outcome. Evidence of
inverse associations with the outcome of gestational IGT only were
also observed for these two contaminants (p-value for trend¼0.07
for DMP, 0.12 for DMTP). Signiﬁcantly reduced odds of gestational
IGT were also observed in the third quartile of DEP (OR¼0.2, 95%
CI¼0.1–0.6).
A signiﬁcant dose-response relationship was observed in the
cubic spline model between dimethyl OP metabolites and odds of
GDM (p¼0.02 for both exposures) (Fig. 1). A test of the null hy-
pothesis that the relationship between dimethyl metabolite levels
and odds of GDM is linear was not rejected (p¼0.19), suggesting a
linear association. An association of borderline signiﬁcance was
observed in the cubic spline model for DEP and odds of gestational
IGT (p¼0.08), with statistical evidence of a non-linear association
(p¼0.03 for test of non-linearity) (Fig. 1).
In examining associations between PFASs and study outcomes,
elevated odds of gestational IGT were observed in the second
quartile of PFHxS (OR¼3.5, 95% CI¼1.4–8.9) in adjusted analyses.
A similar pattern, but with an attenuated odds ratio, was observed
for the combined GDM/IGT outcome (adjusted OR for second
quartile¼2.4, 95% CI¼1.3–4.4). A cubic spline model testing the
relationship between PFHxS and gestational IGT did not show
signiﬁcant evidence of an overall association (p¼0.73) (Fig. 2). No
evidence of associations with GDM or gestational IGT was ob-
served for PCBs or OC pesticides (Table 3).4. Discussion
In this longitudinal birth cohort study of Canadian women, we
evaluated the associations between maternal concentrations of OP
and OC pesticides, PFASs and PCBs with gestational IGT and GDM.
After adjustment for potential confounding variables, we observed
Table 3
Odds ratios (95% CI) for GDM, gestational IGT, and GDM or gestational IGT by contaminant quartiles.
Contaminant (μg/L) GDM (N¼44) vs. Normal Glucose (N¼1102)a Gestational IGT (N¼49) vs. Normal Glucose
(N¼1102)a
GDM or gestational IGT (N¼93) vs. Normal Glucose
(N¼1102)a
Unadjusted ORb (95%
CI)
Adjusted ORc (95%
CI)
Unadjusted OR (95% CI) Adjusted ORc (95% CI) Unadjusted OR (95% CI) Adjustedc OR (95% CI)
Organophosphorus pesticide metabolites
DEP Q1 (0.5–1.1) 1 1 1 1 1 1
Q2 (1.2–2.1) 1.2 (0.5–2.9) 1.1 (0.4–2.8) 0.6 (0.3–1.4) 0.5 (0.2–1.2) 0.9 (0.5–1.6) 0.7 (0.4–1.4)
Q3 (2.2–4.5) 1.0 (0.4–2.4) 0.9 (0.3–2.5) 0.3 (0.1–0.8) 0.2 (0.1–0.6) 0.5 (0.3–1.1) 0.4 (0.2–0.9)
Q4 (4.6–96) 1.2 (0.5–2.8) 1.2 (0.4–3.7) 1.1 (0.6–2.3) 0.8 (0.3–2.0) 1.1 (0.7–2.0) 0.9 (0.4–1.9)
p-valued 0.85 0.41 0.58
DMP Q1 (0.5–1.2) 1 1 1 1 1 1
Q2 (1.3–3) 1.0 (0.5–2.1) 0.8 (0.4–1.8) 0.6 (0.3–1.4) 0.6 (0.2–1.3) 0.8 (0.5–1.4) 0.7 (0.4–1.2)
Q3 (3.1–6.5) 0.3 (0.1–0.9) 0.2 (0.1–0.7) 0.7 (0.3–1.5) 0.5 (0.2–1.1) 0.5 (0.3–0.9) 0.3 (0.2–0.7)
Q4 (6.6–190) 0.5 (0.2–1.3) 0.3 (0.1–0.8) 0.6 (0.3–1.4) 0.4 (0.2–1.1) 0.6 (0.3–1.1) 0.3 (0.2–0.7)
p-valued o0.01 0.07 o0.01
DMTP Q1 (0.3–0.99) 1 1 1 1 1 1
Q2 (1–3.4) 0.8 (0.4–1.7) 0.8 (0.3–1.7) 1.3 (0.6–2.8) 1.3 (0.6–2.9) 1.0 (0.6–1.7) 1.0 (0.6–1.8)
Q3 (3.5–9.3) 0.5 (0.2–1.2) 0.5 (0.2–1.2) 1.0 (0.4–2.3) 0.9 (0.4–2.1) 0.7 (0.4–1.3) 0.6 (0.3–1.2)
Q4 (9.4–420) 0.4 (0.1–0.9) 0.3 (0.1–0.9) 0.6 (0.2–1.4) 0.5 (0.2–1.4) 0.4 (0.2–0.9) 0.4 (0.2–0.8)
p-valued 0.01 0.12 0.01
Dimethyl OP metabolites (DMP and
DMTP, nmol/L)
Q1 (2.5–26.4) 1 1 1 1 1 1
Q2 (26.5–58.7) 0.5 (0.2–1.1) 0.5 (0.2–1.1) 1.5 (0.7–3.1) 1.6 (0.7–3.3) 0.9 (0.5–1.5) 0.9 (0.5–1.6)
Q3 (58.9–120.3) 0.4 (0.2–1.0) 0.5 (0.2–1.0) 0.5 (0.2–1.3) 0.5 (0.2–1.4) 0.5 (0.2–0.9) 0.5 (0.3–0.9)
Q4 (120.4–
1615.2)
0.3 (0.1–0.8) 0.3 (0.1–0.8) 0.6 (0.2–1.4) 0.7 (0.3–1.7) 0.4 (0.2–0.8) 0.5 (0.2–0.9)
p-valued 0.01 0.11 o0.01
Organochlorine pesticides
DDE Q1 (0.05–0.21) 1 1 1 1 1 1
Q2 (0.22–0.31) 1.4 (0.6–3.5) 1.4 (0.6–3.5) 0.7 (0.3–1.6) 0.7 (0.3–1.7) 1.0 (0.5–1.8) 1.0 (0.5–1.8)
Q3 (0.32–0.49) 0.7 (0.3–2.0) 0.5 (0.2–1.6) 1.0 (0.5–2.1) 1.0 (0.4–2.2) 0.9 (0.5–1.7) 0.8 (0.4–1.5)
Q4 (0.5–26) 2.0 (0.9–4.7) 1.1 (0.4–2.9) 0.6 (0.3–1.5) 0.6 (0.2–1.6) 1.2 (0.7–2.1) 0.8 (0.4–1.6)
p-valued 0.74 0.49 0.43
Oxychlordane Q1 (0.003-
0.009)
1 1 1 1 1 1
Q2 (0.009–
0.013)
1.2 (0.5–2.8) 1.0 (0.4–2.4) 0.8 (0.4–1.8) 0.8 (0.3–1.7) 0.9 (0.5–1.7) 0.9 (0.5–1.6)
Q3 (0.014–
0.018)
0.9 (0.3–2.4) 0.8 (0.3–2.3) 0.6 (0.2–1.5) 0.6 (0.2–1.5) 0.7 (0.4–1.4) 0.6 (0.3–1.3)
Q4 (0.019–
0.130)
1.7 (0.7–3.9) 1.1 (0.4–2.8) 1.1 (0.5–2.5) 0.9 (0.4–2.3) 1.4 (0.8–2.4) 1.0 (0.5–1.9)
p-valued 0.95 0.83 0.82
Trans-nonachlor Q1 (0.005–
0.012)
1 1 1 1 1 1
Q2 (0.013–
0.018)
0.6 (0.2–1.6) 0.6 (0.2–1.6) 0.6 (0.3–1.4) 0.7 (0.3–1.6) 0.6 (0.3–1.2) 0.6 (0.3–1.2)
Q3 (0.019–
0.027)
1.3 (0.6–3.0) 1.2 (0.5–2.9) 0.7 (0.3–1.6) 0.7 (0.3–1.7) 0.9 (0.5–1.7) 0.9 (0.5–1.6)
Q4 (0.028–0.23) 1.7 (0.7–3.8) 1.2 (0.5–3.2) 0.9 (0.4–1.9) 0.8 (0.3–1.9) 1.2 (0.7–2.1) 0.9 (0.5–1.9)
p-valued 0.40 0.62 0.88
Perﬂuoroalkyl substances
PFOA Q1 (0.05–1.2) 1 1 1 1 1 1
Q2 (1.3–1.7) 0.9 (0.4–2.0) 0.9 (0.4–2.1) 1.1 (0.5–2.3) 0.9 (0.4–2.0) 1.0 (0.5–1.7) 0.9 (0.5–1.6)
Q3 (1.8–2.5) 0.9 (0.4–2.0) 1.0 (0.4–2.2) 0.9 (0.4–1.9) 0.7 (0.3–1.6) 0.9 (0.5–1.6) 0.8 (0.5–1.5)
Q4 (2.6–16) 0.6 (0.2–1.6) 0.9 (0.3–2.3) 0.7 (0.3–1.6) 0.7 (0.3–1.8) 0.6 (0.3–1.2) 0.8 (0.4–1.5)
p-valued 0.86 0.36 0.44
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Table 3 (continued )
Contaminant (μg/L) GDM (N¼44) vs. Normal Glucose (N¼1102)a Gestational IGT (N¼49) vs. Normal Glucose
(N¼1102)a
GDM or gestational IGT (N¼93) vs. Normal Glucose
(N¼1102)a
Unadjusted ORb (95%
CI)
Adjusted ORc (95%
CI)
Unadjusted OR (95% CI) Adjusted ORc (95% CI) Unadjusted OR (95% CI) Adjustedc OR (95% CI)
PFOS Q1 (0.15–3.3) 1 1 1 1 1 1
Q2 (3.4–4.6) 0.6 (0.3–1.5) 0.6 (0.3–1.6) 1.4 (0.6–3.0) 1.2 (0.5–2.8) 0.9 (0.5–1.7) 0.9 (0.5–1.7)
Q3 (4.7–6.8) 0.9 (0.4–2.0) 1.1 (0.5–2.5) 1.4 (0.6–3.1) 1.2 (0.6–2.8) 1.1 (0.6–2.0) 1.2 (0.6–2.1)
Q4 (6.9–36) 0.6 (0.2–1.4) 0.7 (0.3–1.7) 0.8 (0.3–2.0) 0.8 (0.3–2.1) 0.7 (0.4–1.3) 0.7 (0.4–1.4)
p-valued 0.70 0.74 0.59
PFHxS Q1 (0.1-0.66) 1 1 1 1 1 1
Q2 (0.67–1) 1.4 (0.6–3.3) 1.6 (0.7–3.8) 3.5 (1.4–8.8) 3.5 (1.4–8.9) 2.2 (1.2–4.1) 2.4 (1.3–4.4)
Q3 (1.1–1.6) 1.2 (0.5–2.8) 1.4 (0.6–3.5) 1.4 (0.5–4.1) 1.3 (0.5–4.0) 1.3 (0.6–2.5) 1.3 (0.6–2.7)
Q4 (1.7–40) 0.8 (0.3–2.0) 1.2 (0.4–3.5) 2.4 (0.9–6.3) 2.5 (0.9–7.0) 1.4 (0.7–2.7) 1.8 (0.9–3.6)
p-valued 0.73 0.44 0.47
Polychlorinated biphenyls
PCB118 Q1 (0.005–0.01) 1 1 1 1 1 1
Q2 (0.011–
0.015)
1.2 (0.5–2.9) 1.0 (0.4–2.6) 0.8 (0.4–1.8) 0.8 (0.4–1.8) 1.0 (0.5–1.8) 0.9 (0.5–1.6)
Q3 (0.016–
0.022)
1.3 (0.5–3.1) 0.9 (0.3–2.5) 0.7 (0.3–1.7) 0.6 (0.3–1.6) 0.9 (0.5–1.8) 0.7 (0.4–1.4)
Q4 (0.023–0.22) 1.7 (0.7–4.0) 1.4 (0.5–3.5) 1.0 (0.5–2.2) 0.9 (0.4–2.2) 1.3 (0.7–2.3) 1.1 (0.6–2.1)
p-valued 0.55 0.79 0.90
PCB138 Q1 (0.005–
0.017)
1 1 1 1 1 1
Q2 (0.018–
0.026)
2.0 (0.8–4.9) 1.8 (0.7–4.8) 0.6 (0.2–1.3) 0.6 (0.3–1.4) 1.0 (0.5–1.8) 1.0 (0.5–1.8)
Q3 (0.027–0.04) 1.5 (0.6–3.9) 1.3 (0.5–3.8) 0.7 (0.3–1.5) 0.7 (0.3–1.6) 0.9 (0.5–1.7) 0.9 (0.4–1.7)
Q4 (0.041–0.43) 1.9 (0.7–4.8) 1.5 (0.5–4.2) 0.8 (0.4–1.6) 0.8 (0.3–1.8) 1.1 (0.6–2.0) 1.0 (0.5–1.9)
p–valued 0.71 0.60 0.86
PCB153 Q1 (0.005–
0.029)
1 1 1 1 1 1
Q2 (0.03–0.044) 1.8 (0.7–4.4) 1.9 (0.7–4.8) 0.5 (0.2–1.2) 0.6 (0.2–1.3) 0.9 (0.5–1.7) 0.9 (0.5–1.8)
Q3 (0.045–0.07) 1.1 (0.4–2.9) 1.0 (0.3–3.0) 0.6 (0.3–1.4) 0.6 (0.2–1.4) 0.8 (0.4–1.4) 0.7 (0.4–1.4)
Q4 (0.071–0.93) 1.6 (0.7–4.0) 1.4 (0.5–4.1) 0.7 (0.3–1.4) 0.7 (0.3–1.7) 1.0 (0.5–1.7) 0.9 (0.5–1.8)
p-valued 0.82 0.42 0.65
PCB180 Q1 (0.005–
0.019)
1 1 1 1 1 1
Q2 (0.02–0.03) 1.4 (0.6–3.2) 1.5 (0.6–3.8) 0.6 (0.3–1.2) 0.5 (0.2–1.3) 0.9 (0.5–1.5) 0.9 (0.5–1.6)
Q3 (0.031–
0.049)
0.8 (0.3–2.0) 0.7 (0.2–2.2) 0.4 (0.2–1.0) 0.4 (0.1–1.1) 0.5 (0.3–1.1) 0.5 (0.2–1.1)
Q4 (0.05–1.1) 1.3 (0.6–3.1) 1.3 (0.5–3.5) 0.7 (0.4–1.6) 0.7 (0.3–1.8) 1.0 (0.5–1.7) 0.9 (0.5–1.8)
p-valued 0.98 0.48 0.60
Sum of all PCBs Q1 (0.02–0.075) 1 1 1 1 1 1
Q2 (0.076–
0.116)
1.6 (0.7–3.7) 1.4 (0.6–3.6) 0.6 (0.3–1.3) 0.6 (0.3–1.5) 1.0 (0.5–1.7) 0.9 (0.5–1.7)
Q3 (0.117–0.179) 0.8 (0.3–2.2) 0.7 (0.2–2.0) 0.5 (0.2–1.2) 0.5 (0.2–1.2) 0.6 (0.3–1.2) 0.6 (0.3–1.1)
Q4 (0.181–
2.491)
1.3 (0.5–3.0) 1.0 (0.3–2.7) 0.8 (0.4–1.6) 0.8 (0.3–2.0) 0.9 (0.5–1.7) 0.8 (0.4–1.7)
p-valued 0.60 0.58 0.43
Sum of non-dioxin-like PCBs (138, 153,
180)
Q1 (0.015–
0.065)
1 1 1 1 1 1
Q2 (0.066–0.1) 1.8 (0.8–4.4) 1.9 (0.7–4.7) 0.6 (0.3–1.4) 0.6 (0.3–1.5) 1.0 (0.6–1.8) 1.0 (0.5–1.9)
Q3 (0.101–
0.158)
0.9 (0.3–2.5) 0.8 (0.3–2.5) 0.5 (0.2–1.2) 0.5 (0.2–1.3) 0.6 (0.3–1.2) 0.6 (0.3–1.2)
Q4 (0.159–2.46) 1.6 (0.6–3.8) 1.3 (0.5–3.8) 0.8 (0.4–1.7) 0.8 (0.3–2.1) 1.0 (0.6–1.9) 1.0 (0.5–2.0)
p-valued 0.97 0.65 0.70
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G.D. Shapiro et al. / Environmental Research 147 (2016) 71–81 77statistical evidence of inverse associations between urine con-
centrations of two OP pesticide metabolites, DMP and DMTP, with
GDM, and GDM and IGT combined. We found no consistent evi-
dence of an association between levels of the other chemicals we
examined and GDM or gestational IGT in the adjusted analyses.
The inverse associations we observed between DMP and DMTP
with GDM are puzzling and, to our knowledge, have not been
reported in previous studies. OP pesticides are hypothesized to
increase the risk of diabetes through accumulation of acetylcho-
line leading to increased mobilization of glucose, but acetylcholine
could also lead to increased insulin secretion in some cases, which
would likely be protective against GDM (Rodriguez-Diaz et al.,
2011), and hypoglycemia has been observed following exposure to
OP pesticides in some experimental studies using animal models
(Rahimi and Abdollahi, 2007). We cannot rule out the inﬂuence of
residual confounding due to unmeasured protective factors, such
as nutritional beneﬁts from consumption of fruits and vegetables
also associated with pesticide exposure, on the observed associa-
tions between maternal OP pesticide metabolites and GDM. A
recent literature review found that the nutritional exposures
showing the most salient relationships with increased risk of GDM
were higher dietary fat and lower carbohydrate intakes (Morisset
et al., 2010). While a protective effect of fruit and vegetable con-
sumption for GDM has not been demonstrated, fruits and vege-
tables are likely to displace fat in the diet, as they are high ﬁbre /
high satiety foods. Furthermore, women who consume high levels
of fruit and vegetables may also be at reduced risk for GDM due to
other lifestyle variables that we did not measure, such as physical
activity. The dietary measurements in the MIREC Study were not
designed to measure fruit and vegetable consumption and in-
cluded only select fruits and vegetables. Thus, we are unable to
test the role that this potential bias may play in our ﬁndings.
The epidemiologic literature examining the association be-
tween OP pesticides and diabetes has primarily occurred in oc-
cupationally exposed populations. In one of the few cohort studies
examining the association between pesticide exposure and GDM,
self-reported exposure to two organophosphate pesticides (diazi-
non, phorate) during the ﬁrst trimester were associated with an
increased risk of GDM though the number of exposed cases was
relatively small (Saldana et al., 2007). Another study also reported
positive associations between OP pesticide exposure and incident
diabetes among famers’ wives (Starling, 2014) and among male
farmers (Montgomery et al., 2008). Unlike the MIREC Study, these
studies used self-reported data for both exposure and outcome
assessments. Comparison of our results and these previous studies
is challenged by differences in study sample (with MIREC being a
primarily urban sample with low chronic exposure, primarily from
the diet) and exposure assessment methods (biomarker vs. self-
reported).
Not surprisingly, the OP pesticide metabolite concentrations in
the MIREC cohort were lower than reported in residents or
workers of agricultural communities. OP metabolite concentra-
tions among MIREC participants were lower than reported in a
cohort of pregnant women living in an agricultural community in
California (Bradman et al., 2005), in a cohort of pregnant women
without diabetes living in agricultural areas in Thailand (Kongtip
et al., 2014), and in a cohort of Japanese workers with environ-
mental or occupational exposures to OPs (Ueyama et al., 2012).
Thus, the lower concentrations in the MIREC study may contribute
to differences in the observed results and positive associations
reported in occupationally exposed populations. When compared
to non-agricultural cohorts, OP pesticide metabolite concentra-
tions were similar or higher in the MIREC cohort compared to
other general population cohorts (Berman et al., 2013). Con-
centrations of OP pesticide metabolites in our study were higher
than reported in the U.S. NHANES (Barr et al., 2011).
Fig. 1. Restricted spline curve associations between log10 organophosphorus pesticide metabolites and log odds of study outcomes, adjusted for maternal age, race, pre-
pregnancy BMI, education and urinary speciﬁc gravity. Knots were located at the 5th, 50th and 95th percentiles. Dashed lines¼95% CI; dots¼knots.
Fig. 2. Restricted spline curve association between log10 PFHxS (μg/L) and log odds
of gestational IGT, adjusted for maternal age, race, pre-pregnancy BMI and educa-
tion. Knots were located at the 5th, 50th and 95th percentiles. Dashed lines¼95%
CI; dots¼knots.
G.D. Shapiro et al. / Environmental Research 147 (2016) 71–8178Concentrations of DMTP were higher in MIREC participants than
among women age 20–39 in Cycle 1 of the Canadian Health
Measures Survey (CHMS), while levels of DEP and DMP were si-
milar between the two studies (Health Canada, 2010).
Literature regarding associations between the other chemical
classes measured in this study and diabetes among pregnant po-
pulations is scarce. Studies that have examined potential associa-
tions between diabetes and exposure to organochlorine pesticides,
PCBs, and PFASs have largely focused on type 2 diabetes or self-
reported diabetes. For example, positive associations between OC
pesticides and diabetes have been identiﬁed in U.S. NHANES(Everett and Matheson, 2010; Lee et al., 2006), the Hispanic Health
and Nutrition Study (Cox et al., 2007), a Helsinki cohort study
(Airaksinen et al., 2011), and a cross-sectional analysis of Great
Lakes sport ﬁsh consumers (Turyk et al., 2009b). In contrast, null
or negative results have also been reported between OC pesticides
and diabetes (Gasull et al., 2012; Wu et al., 2013).
Literature regarding the association between PFAS exposure
and diabetes is equivocal, with cohort (Leonard et al., 2008; Lun-
din et al., 2009) and cross-sectional analyses (Lin et al., 2009) re-
porting both positive (Leonard et al., 2008; Lundin et al., 2009)
(Lin et al., 2009) and negative or null ﬁndings (Karnes et al., 2014;
Lind et al., 2014; MacNeil et al., 2009; Nelson et al., 2010). A recent
study of PFAS exposure and GDM found a positive association for
PFOA, with no signiﬁcant associations found for six other PFASs
(Zhang et al., 2015). While we did not ﬁnd statistical evidence of
associations between PFASs and our study outcomes in cubic
spline models, results from our regression analysis on PFHxS and
gestational IGT are consistent with a low-dose effects hypothesis.
Associations between low doses of other persistent organic pol-
lutants have been reported with incident diabetes (Lee et al., 2010)
and metabolic precursors to diabetes (Lee et al., 2011).
PCB exposure has been found to be associated with diabetes
though, to our knowledge, no identiﬁed study has focussed on
prenatal exposure and GDM. Analysis from a pregnancy cohort of
similar size to the MIREC Study showed a dose-response re-
lationship between total serum PCBs and prevalent diabetes,
though authors did not show results separately for GDM (Long-
necker et al., 2001). A cross-sectional study of 40 pregnant women
without diabetes found that PCB concentration was associated
with reduced insulin sensitivity after adjustment for age and pre-
pregnancy BMI (Chen et al., 2008). PCBs examined in one study
were also associated with markers of insulin in women with a
history of GDM (Arrebola et al., 2015).
It is plausible that the lack of positive association between
these contaminants and GDM in the present study stems from low
overall exposure levels in the MIREC cohort. The OC pesticide
concentrations in our study are substantially lower than in studies
that found associations with type 2 diabetes (Cox et al., 2007; Lee
et al., 2011a, 2010; Philibert et al., 2009; Porta et al., 2012; Rignell-
Hydbom et al., 2009; Son et al., 2010; Turyk et al., 2009b). Our
observed concentrations of DDE were also slightly lower than
G.D. Shapiro et al. / Environmental Research 147 (2016) 71–81 79those for women of childbearing age in the CHMS, while con-
centrations of oxychlordane and trans-nonachlor were similar
between the two studies (Health Canada, 2010).
Plasma PFAS concentrations were lower in the MIREC cohort
than in most of the studies we reviewed (Fei et al., 2007; Lin et al.,
2009; Lind et al., 2014; MacNeil et al., 2009; Melzer et al., 2010;
Nelson et al., 2010). PCB levels were also several times lower in our
study compared to other population-based samples (Gasull et al.,
2012; Lee et al., 2010; Porta et al., 2012). Our observed PCB con-
centrations were similar or lower than those measured in a US
cohort (Sexton et al., 2013) and in the CHMS (Health Canada,
2010).
4.1. Strengths and limitations
There were a substantial number of subjects for whom a GCT
was not performed and who were therefore excluded from our
analyses, reducing statistical power. However, given the small
magnitude of the differences between included and excluded
participants on demographic variables, we do not expect that our
ﬁndings would be strongly affected by selection bias. It should be
acknowledged that ﬁndings from the regression analyses are
based on small numbers of cases in each quartile. Therefore, some
of our negative ﬁndings may be due to type 2 error. Additionally,
while we were able to adjust for a wide range of potential con-
founding variables, there remains a possibility of residual con-
founding by dietary intake or other factors not measured. Speci-
ﬁcally, data were not collected on the presence of diabetes in re-
latives of MIREC Study participants, and family history of diabetes
may constitute an unmeasured confounding variable. In light of
the observed correlations across exposure classes and the ex-
ploratory nature of our study, we examined only individual ex-
posures and chemical classes. Future work should explore the
impact of sums of different types of exposures.
An important limitation of our analysis is the use of a single ur-
inary measure for OP pesticide metabolites. As these chemicals have
short elimination half-lives (Lambert et al., 2005; Lu et al., 2008;
Rauch et al., 2012), within-person reliability in urinary OP metabolite
concentrations has been reported as weak to moderate, with in-
traclass correlation coefﬁcients ranging from 0.21 to 0.33 for the
metabolites that we examined (Spaan et al., 2015). Thus our use of a
single measurement may not reﬂect overall exposure in pregnancy.
Future studies incorporating multiple measurements are needed to
better illuminate variation in levels and effects of OP pesticides across
pregnancy.
The MIREC study sample exhibits a low-risk socioeconomic
proﬁle in terms of education, nativity, smoking and marital status,
compared to the overall Canadian population giving birth at the
time the MIREC participants were recruited (Arbuckle et al., 2013).
Our results therefore may have limited generalizability to other
populations with differing socioeconomic characteristics and ex-
posure patterns, particularly those with occupational exposure to
the chemicals we examined. Along these lines, our analyses were
limited to chemical exposures for which there were detectable
levels in 475% of subjects. This resulted in the exclusion of several
chemicals assessed in the MIREC Study, including three OP pesti-
cide metabolites, eight OC pesticides, and 20 PCBs. Further study
of these chemicals in relation to diabetes may be warranted, par-
ticularly in areas with higher concentrations.
These limitations must be weighed against several important
strengths of our study, including the prospective study design and the
comprehensive questionnaire data and anthropometric measure-
ments collected in the MIREC Study, which enabled us to control for a
rich variety of potential confounding variables. We also measured our
study outcomes from medical charts using standard guidelines, rather
than relying on self-reported outcome measures.5. Conclusions
Using a prospective cohort design, we evaluated the relation-
ships between OP and OC pesticides, PFASs, and PCBs measured
during the ﬁrst trimester of pregnancy with risk of being diag-
nosed with GDM or gestational IGT based on published national
guidelines. Though we did not ﬁnd consistent evidence for any
positive associations between the chemicals we examined and
GDM or gestational IGT, we observed strong inverse associations
between dimethyl OP pesticide metabolites and GDM. These
ﬁndings require further investigation in other populations.Funding sources
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